In vitro susceptibility testing of filamentous fungi: Comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs

被引:38
作者
Pfaller, MA [1 ]
Messer, SA
Boyken, L
Hollis, RJ
Diekema, DJ
机构
[1] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
关键词
Etest; posaconazole; molds;
D O I
10.1016/S0732-8893(02)00544-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The performance of the Etest for posaconazole susceptibility testing of 72 isolates of filamentous fungi was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS) approved standard broth microdilution method (M38-A). The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48h at 35 degreesC. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48h at 35 degreesC. The isolates included Aspergillus fumigatus, A. flavus, A. nidulans, A. niger, A. versicolor, A. oryzae, A. terreus, Cladosporium spp., Curvularia sp., Exophiala sp., Fusarium spp., Paecilomyces spp., Pithomyces sp.. Penicillium spp. and Scedosporium apiospermum. Overall agreement between Etest and microdilution MICs was 84% for Aspergillus spp. and 100% for the less common opportunistic molds, with the exception of Penicillium spp. (67%). Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values. The Etest method using RPMI agar appears to be a useful method for determining posaconazole susceptibilities of filamentous fungi. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 32 条
[21]   Azole cross-resistance in Aspergillus fumigatus [J].
Mosquera, J ;
Denning, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :556-557
[22]  
NCCLS (National Committee for Clinical Laboratory Standards), 2002, M38A NCCLS
[23]   Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus [J].
Oakley, KL ;
Morrissey, G ;
Denning, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1504-1507
[24]   Invasive mycoses: management and unmet medical needs [J].
Patterson, TF .
CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (06) :669-671
[25]   Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia [J].
Petraitiene, R ;
Petraitis, V ;
Groll, AH ;
Sein, T ;
Piscitelli, S ;
Candelario, M ;
Field-Ridley, A ;
Avila, N ;
Bacher, J ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :857-869
[26]   In vitro susceptibility testing of filamentous fungi:: Comparison of Etest and reference microdilution methods for determining itraconazole MICs [J].
Pfaller, MA ;
Messer, SA ;
Mills, K ;
Bolmström, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3359-3361
[27]   In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans [J].
Pfaller, MA ;
Messer, SA ;
Hollis, RJ ;
Jones, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2862-2864
[28]   Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi:: Report from SENTRY Antimicrobial Surveillance Program, 2000 [J].
Pfaller, MA ;
Messer, SA ;
Hollis, RJ ;
Jones, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1032-1037
[29]  
Rees JR, 1998, CLIN INFECT DIS, V27, P1138, DOI 10.1093/clinids/27.5.1138
[30]   Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient:: Species identification and review of the literature [J].
Richter, S ;
Cormican, MG ;
Pfaller, MA ;
Lee, CK ;
Gingrich, R ;
Rinaldi, MG ;
Sutton, DA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1154-1160